Multimedia

VIDEO - Covid-19 vaccine for 12+ kids by Oct: Zydus’ Sharvil Patel

By Gina Krishnan

September 14, 2021 at 5:26 PM

Zydus prepares to roll out the first and only needle-free vaccine. It is India’s first recombinant, DNA based vaccine developed indigenously in its labs.

Managing Director Dr Sharvil Patel speaks to Fortune India on life turned on its head by Covid-19 and the company's focus on innovation after vaccine development.

Follow us on Facebook, X, YouTube, Instagram and WhatsApp to never miss an update from Fortune India. To buy a copy, visit Amazon.

Tata Technologies FY24 profit surges 9% at ₹679 cr; revenue grows 16%
May 03, 2024 at 5:48 PM
WhatsApp India bans 2.2 crore accounts in Jan-March
May 03, 2024 at 6:02 PM
Titan Q4 profit rises 5% to ₹771 crore
May 03, 2024 at 5:40 PM
Adani Green Q4 profit drops 39% to ₹310 cr
May 03, 2024 at 4:15 PM
Godrej Properties Q4 profit up 14%; revenue down 13% to ₹1,426 cr
May 03, 2024 at 4:14 PM

Multimedia

VIDEO - Covid-19 vaccine for 12+ kids by Oct: Zydus’ Sharvil Patel

Also Read

Tata Technologies FY24 profit surges 9% at ₹679 cr; revenue grows 16%

WhatsApp India bans 2.2 crore accounts in Jan-March

Titan Q4 profit rises 5% to ₹771 crore

Adani Green Q4 profit drops 39% to ₹310 cr

Godrej Properties Q4 profit up 14%; revenue down 13% to ₹1,426 cr